MedTrace Logo

E-health-supported Diagnostic and Intervention in Preterm Born Children and Their Families

NCT06939192 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-04-22

No results posted yet for this study

Summary

The app-based diagnostic and support approach with a focus on mental and somatic symptoms is intended to strengthen the resilience of premature born children and families and to identify risk and resilience factors.The overall objective of the study is to improve the post-inpatient care of families with premature born children. The procedure is evaluated by a two-arm design with an experimental group and a TAU group.

Conditions

Interventions

OTHER

Intervention Group (APP)

Combination of app-based information and diagnostic screening for parents of premature babies.

OTHER

Treatment as usual-Group (TAU)

No intervention. Treatment in the form of usual aftercare service is possible.

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Annette Conzelmann, Prof. Dr. · Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Tübingen

  • Annika K Alt · Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Tübingen

  • Tobias J Renner, Prof. Dr. · Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Tübingen

  • Axel Franz, Prof. Dr. · Neonatology, University of Tübingen

  • Mirja Quante, Dr. · Neonatology, University of Tübingen

  • Michaela Minarski, Dr. · Neonatology, University of Tübingen

  • Johanna Löchner, Prof. Dr. · Clinical Psychology, FAU Erlangen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
28 Weeks
Max Age
34 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06939192 on ClinicalTrials.gov